Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 30, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 30, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 644 Common Stock at $523.04 ($336,837) on July 30, 2026; holds 333,299 after (Indirect).
- Open-market sale: disposed of 1,486 Common Stock at $523.87 ($778,478) on July 30, 2026; holds 331,813 after (Indirect).
- Open-market sale: disposed of 4,846 Common Stock at $524.88 ($2,543,589) on July 30, 2026; holds 326,967 after (Indirect).
- Open-market sale: disposed of 2,084 Common Stock at $525.80 ($1,095,763) on July 30, 2026; holds 324,883 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $526.92 ($210,769) on July 30, 2026; holds 324,483 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $528.96 ($21,158) on July 30, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 30, 2026; holds 236,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,986,594 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-30 | Open-market sale | Common Stock | 644 | $523 | $336.8K | 333,299 |
| 2026-07-30 | Open-market sale | Common Stock | 1,486 | $524 | $778.5K | 331,813 |
| 2026-07-30 | Open-market sale | Common Stock | 4,846 | $525 | $2.5M | 326,967 |
| 2026-07-30 | Open-market sale | Common Stock | 2,084 | $526 | $1.1M | 324,883 |
| 2026-07-30 | Open-market sale | Common Stock | 400 | $527 | $210.8K | 324,483 |
| 2026-07-30 | Open-market sale | Common Stock | 40 | $529 | $21.2K | 324,443 |
| 2026-07-30 | Option exercise/conversion | Stock Option | 9,500 | — | — | 236,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Option exercise/conversion (9,500 shares) |
| 2026-07-30 | Open-market sale (644 shares) |
| 2026-07-30 | Open-market sale (1,486 shares) |
| 2026-07-30 | Open-market sale (4,846 shares) |
| 2026-07-30 | Open-market sale (2,084 shares) |
| 2026-07-30 | Open-market sale (400 shares) |
| 2026-07-30 | Open-market sale (40 shares) |
| 2026-07-30 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.